MMP2 and medulloblastoma: Furthermore, a recent study by Jackson et al. [75] demonstrated that metastatic medulloblastoma cells released a higher amount of EVs compared to non-metastatic cells, and metastatic EVs significantly increased surface matrix metalloproteinase-2 (MMP-2).